Correlation Between Revelation Biosciences and Silo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Silo Pharma, you can compare the effects of market volatilities on Revelation Biosciences and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Silo Pharma.

Diversification Opportunities for Revelation Biosciences and Silo Pharma

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Revelation and Silo is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Silo Pharma go up and down completely randomly.

Pair Corralation between Revelation Biosciences and Silo Pharma

Assuming the 90 days horizon Revelation Biosciences is expected to generate 8.31 times more return on investment than Silo Pharma. However, Revelation Biosciences is 8.31 times more volatile than Silo Pharma. It trades about 0.08 of its potential returns per unit of risk. Silo Pharma is currently generating about 0.0 per unit of risk. If you would invest  2.13  in Revelation Biosciences on September 2, 2024 and sell it today you would lose (0.91) from holding Revelation Biosciences or give up 42.72% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.36%
ValuesDaily Returns

Revelation Biosciences  vs.  Silo Pharma

 Performance 
       Timeline  
Revelation Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Revelation Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Revelation Biosciences may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Silo Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Silo Pharma is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Revelation Biosciences and Silo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Revelation Biosciences and Silo Pharma

The main advantage of trading using opposite Revelation Biosciences and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.
The idea behind Revelation Biosciences and Silo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stocks Directory
Find actively traded stocks across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.